Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03585972 · ClinicalTrials.gov registry record · NA

Frailty Prevention Program to Prevent Frailty Among Older African Americans

A NA study, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03585972 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03585972, a NA study, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Between 20-60% of older adults experience frailty as they age. Frailty is a clinical state of increased vulnerability resulting from aging-associated declines in biological reserve across multiple physiologic systems. Because of the lack of biological reserve, relatively minor physical or psychological assaults have the potential to trigger a cascade of negative sequelae for frail older adults resulting in adverse health outcomes including mortality, disability in basic and instrumental activities of daily living, hospitalization and emergency visits, and institutionalization in community-dwelling older adults. Despite the potential personal and economic consequences of frailty syndrome, frailty is not an irreversible process. For example, a 4.5-year longitudinal study conducted by Gill et al., (2006) demonstrated that of their 754 community dwelling older adults, 58% had at least one change in frailty status during the study period and that approximately one third of these transitions were from a state of greater frailty to one of lesser frailty, suggesting that it is possible to reverse the frailty trajectory. Nonetheless, there is a lack effective means of reversing frailty or slowing the progression of older adults along the frailty continuum.The purpose of the proposed research is to evaluate the feasibility and preliminary effectiveness of an occupational therapy intervention delivered through the primary care setting for improving frailty status and physical functioning among older adults ages 55 and older who are pre-frail when compared to usual care.

Interventions

  • BEHAVIORAL Frailty Prevention Program

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-05-05
Est. Completion 2019-05-28
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT03585972

The ClinicalTrials.gov registry entry for NCT03585972 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Frailty Prevention Program is the first listed.

NCT03585972 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03585972 about?

NCT03585972 is a clinical study titled "Frailty Prevention Program to Prevent Frailty Among Older African Americans". Between 20-60% of older adults experience frailty as they age. Frailty is a clinical state of increased vulnerability resulting from aging-associated declines in biological reserve across multiple physiologic systems. Because of the lack of biological reserve, relatively minor physical or psychologi...

What is the current status of trial NCT03585972?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-05-05. Estimated completion is 2019-05-28.

What interventions are being tested in trial NCT03585972?

The interventions under investigation include: Frailty Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03585972?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.